In an ever-evolving landscape, securing investment is more challenging—and critical—than ever. Venture capitalists continue to play a pivotal role in fueling the next wave of breakthrough therapies and devices, but with shifting market dynamics, regulatory pressures, and technological advancements, how can biotech companies position themselves for success? This panel brings together leading investors to provide insights on how to attract funding, prioritize key growth milestones, and balance risk in the pursuit of innovation. Whether you’re navigating early-stage development or preparing for commercialization, understanding the investor perspective is key to driving your company’s future.

• What critical milestones are investors looking for to enhance valuation and attract capital?
• Risk vs. Reward: When should startups and growth companies alike take bold risks in their development pipeline, and when is it smarter to play it safe?
• Investor priorities and top 3 considerations that biotech, medtech, and healthtech executives must prioritize to secure funding in today's market.